Clear Investment Research’s Chemours CC Stock Holding History

Clear Investment Research’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3	Closed	–	–	149
2019 Q3	$0	Hold	3	–	–	﹤0.01%	248
2019 Q2	$0	Hold	3	–	–	﹤0.01%	248
2019 Q1	$0	Hold	3	–	–	﹤0.01%	238
2018 Q4	$0	Hold	3	–	–	﹤0.01%	231
2018 Q3	$0	Buy	+3	New	+$131	﹤0.01%	243

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Clear Investment Research's CC Position: Q4 2019 in Review

Clear Investment Research sold out of Chemours (CC) in Q4 2019, closing a stake of 3 shares.

Clear Investment Research first reported a position in CC in Q3 2018 and held it in 5 quarters. The position peaked at $0 in Q3 2019. 439 funds tracked by Wall St. Rank hold CC as of Q4 2019.

Clear Investment Research reported no remaining Chemours position as of Q4 2019 after selling out during the quarter.
Clear Investment Research sold 3 Chemours shares in Q4 2019.
Clear Investment Research first reported a position in Chemours in Q3 2018 and held it in 5 quarters.
Clear Investment Research's Chemours position peaked at $0 in Q3 2019.
439 funds tracked by Wall St. Rank held Chemours as of Q4 2019.

Based on Clear Investment Research's 13F filing for Q4 2019, filed 4 Feb 2020.